Detalhe da pesquisa
1.
Type I interferon and cancer.
Immunol Rev
; 321(1): 115-127, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667466
2.
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.
Gynecol Oncol
; 162(3): 652-660, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294416
3.
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
Haematologica
; 105(7): 1868-1878, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582537
4.
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.
Cancer Immunol Immunother
; 67(1): 89-100, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28948333
5.
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
Blood
; 128(26): 3113-3124, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802968
6.
High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Int J Cancer
; 135(5): 1165-77, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24500981
7.
Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.
Eur J Immunol
; 43(2): 533-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23124877
8.
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Nat Commun
; 15(1): 2528, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514660
9.
Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
Int J Cancer
; 132(5): 1070-9, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865582
10.
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.
Cancer Immunol Immunother
; 62(2): 321-35, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22923192
11.
Interferon signaling restrains renal cell carcinoma heterogeneity.
Trends Cancer
; 9(11): 871-873, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658022
12.
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822672
13.
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Cell Death Dis
; 14(3): 209, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964168
14.
Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Oncoimmunology
; 12(1): 2219591, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284695
15.
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.
Trends Cancer
; 8(5): 426-444, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181272
16.
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992091
17.
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.
Clin Cancer Res
; 28(14): 3053-3065, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536547
18.
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines.
Oncoimmunology
; 11(1): 2101596, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898703
19.
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
Oncoimmunology
; 11(1): 2096363, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35800158
20.
Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials.
J Transl Med
; 9: 223, 2011 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22208910